Literature DB >> 15038628

Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure.

Kazuomi Kario1, Kazuyuki Shimada.   

Abstract

There is increasing evidence that disruption of diurnal blood pressure (BP) variation is a risk factor for hypertensive target organ damage and cardiovascular events. Especially, the risers (extreme non-dippers), who exhibit a nocturnal BP increase compared with daytime BP, have the worst cardiovascular prognosis, both for stroke and cardiac events. On the other hand, extreme-dippers (with marked nocturnal BP falls) are at risk for non-fatal ischemic stroke and silent myocardial ischemia, particularly extreme-dippers complicated with atherosclerotic arterial stenosis and excessive BP reduction due to antihypertensive medication. Extreme-dipping status of nocturnal BP is closely associated with excessive morning BP surge and orthostatic hypertension. Hypertensive patients who have these conditions and exhibit marked BP variations are likely to have silent cerebral infarct and to be at high-risk with regard to future stroke. Individualized antihypertensive medication targeting disrupted diurnal BP variation might thus be beneficial for such high-risk hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15038628     DOI: 10.1081/ceh-120028556

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  38 in total

Review 1.  Guiding antihypertensive treatment decisions using ambulatory blood pressure monitoring.

Authors:  Giuseppe Mancia; Gianfranco Parati
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

Review 2.  The circadian nuances of hypertension: a reappraisal of 24-h ambulatory blood pressure measurement in clinical practice.

Authors:  E O'Brien
Journal:  Ir J Med Sci       Date:  2007-04-24       Impact factor: 1.568

3.  Desoxycorticosterone pivalate-salt treatment leads to non-dipping hypertension in Per1 knockout mice.

Authors:  K Solocinski; M Holzworth; X Wen; K-Y Cheng; I J Lynch; B D Cain; C S Wingo; M L Gumz
Journal:  Acta Physiol (Oxf)       Date:  2016-10-03       Impact factor: 6.311

Review 4.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

5.  Parenting stress, salivary biomarkers, and ambulatory blood pressure: a comparison between mothers and fathers of children with autism spectrum disorders.

Authors:  Ciara Foody; Jack E James; Geraldine Leader
Journal:  J Autism Dev Disord       Date:  2015-04

6.  Nocturnal systemic hypotension increases the risk of glaucoma progression.

Authors:  Mary E Charlson; Carlos Gustavo de Moraes; Alissa Link; Martin T Wells; Gregory Harmon; Janey C Peterson; Robert Ritch; Jeffrey M Liebmann
Journal:  Ophthalmology       Date:  2014-05-25       Impact factor: 12.079

7.  Renal Na-handling defect associated with PER1-dependent nondipping hypertension in male mice.

Authors:  Lauren G Douma; Meaghan R Holzworth; Kristen Solocinski; Sarah H Masten; Amber H Miller; Kit-Yan Cheng; I Jeanette Lynch; Brian D Cain; Charles S Wingo; Michelle L Gumz
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-10

8.  Female C57BL/6J mice lacking the circadian clock protein PER1 are protected from nondipping hypertension.

Authors:  Lauren G Douma; Kristen Solocinski; Meaghan R Holzworth; G Ryan Crislip; Sarah H Masten; Amber H Miller; Kit-Yan Cheng; I Jeanette Lynch; Brian D Cain; Charles S Wingo; Michelle L Gumz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-11-14       Impact factor: 3.619

9.  Use of ambulatory blood pressure monitoring to guide hypertensive therapy.

Authors:  Amita Singh; Eugenia Gianos; Arthur Schwartzbard; Henry Black; Howard Weintraub
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-12

10.  Bmal1 in Perivascular Adipose Tissue Regulates Resting-Phase Blood Pressure Through Transcriptional Regulation of Angiotensinogen.

Authors:  Lin Chang; Wenhao Xiong; Xiangjie Zhao; Yanbo Fan; Yanhong Guo; Minerva Garcia-Barrio; Jifeng Zhang; Zhisheng Jiang; Jiandie D Lin; Y Eugene Chen
Journal:  Circulation       Date:  2018-01-25       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.